JPRN-jRCT2080223246已完成3 期
A Phase III, randomized double-blind comparative study of KRP-AM1977Y for patients with community acquired pneumonia
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 286
研究概览
简要总结
The non-inferiority of KRP-AM1977Y versus LVFX was demonstrated in the cure rate at the test-of-cure. In the safety assessment, no clinically significant finding was reported in KRP-AM1977Y.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Community acquired pneumonia with clear infection symptoms
排除标准
- •Pneumonia patient except the community-acquired pneumonia
- •Patient with serious functional disorder that would unsuitable for the study
- •Patient showing the tendency to improve pneumonia symptoms by other agents
研究者
相似试验
已完成
3 期
KRP-AM1977X Phase III Comparative Study (Community acquired pneumonia)JPRN-jRCT2080222860Kyorin Pharmaceutical Co.,LTD277
已完成
3 期
KRP-AM1977X Phase III Comparative Study (sinusitis)Sinusitis (severity of infection: moderate to severe)JPRN-jRCT2080222862Kyorin Pharmaceutical Co.,LTD279
已完成
2 期
KRP-AM1977Y Phase II Clinical StudyJPRN-jRCT2080222567Kyorin Pharmaceutical Co.,LTD84
已完成
2 期
KRP-AM1977X Phase II Clinical StudyMild to moderate community acquired pneumonia (including Mycoplasma pneumonia, Chlamydia Pneumonia, or Legionella pneumonia)JPRN-jRCT2080222226Kyorin Pharmaceutical Co.,LTD129
已完成
3 期
Phase III Study of AK-120 in Patients with Recurrent Herpes SimplexRecurrent Herpes Simplex (recurrent herpes labialis and recurrent genital herpes)JPRN-jRCT2080223168Maruho Co.,Ltd.531